Search Within

Nancy Kernan

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (19)
  2. Journal Article (16)
Groups
  1. Bone Marrow Transplant (35)
  2. Center for Hematologic Malignancies (35)
  3. Department of Medicine (35)
  4. GSK Faculty (35)
  5. Hematologic Malignancies, Division of (35)
  6. Human Oncology and Pathogenesis Program (35)

More Groups

People
  1. James Young (33)
  2. Richard O'Reilly (32)
  3. Esperanza Papadopoulos (31)
  4. Miguel-Angel Perales (31)
  5. Ann Jakubowski (29)
  6. Hugo Castro-Malaspina (29)

More People

Years
  1. 2020 (2)
  2. 2017 (2)
  3. 2016 (1)
  4. 2015 (5)
  5. 2014 (1)
  6. 2013 (3)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (19)
  2. Blood (12)
  3. Bone Marrow Transplantation (2)
  4. Journal of Clinical Investigation (1)
  5. New England Journal of Medicine (1)
Publishers
  1. Elsevier Inc. (19)
  2. American Society of Hematology (12)
  3. Nature Publishing Group (2)
  4. American Society for Clinical Investigation (1)
  5. Massachusetts Medical Society (1)

Results (35)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Induction of remission prior to transplantation improves the disease-free survival (DFS) of patients with advanced myelodysplastic syndromes (MDS) treated with myeloablative T-cell depleted (TCD) stem cell transplants (SCT) from HLA identical siblings
    Meeting Abstract

    Castro-Malaspina, H. R.; Jakubowski, A. A.; Papadopoulos, E. B.; Boulad, F.; Young, J. W.; Kernan, N. A.; Perales, M. A.; Small, T. N.; Hsu, K. C.; Chiu, M.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • A phase II trial of a non-myeloablative regimen combining in vivo T cell depletion with an anti-CD52 monoclonal antibody (alemtuzumab), and chemotherapy with fludarabine and melphalan prior to a related or unrelated hematopoietic stem cell transplantation
    Meeting Abstract

    Castro-Malaspina, H.; Papadopoulos, E.; Jakubowski, A.; Perales, M. A.; Young, J.; Hsu, K.; Boulad, F.; Prasad, V.; Small, T.; Kernan, N.; more...
    Biology of Blood and Marrow Transplantation (2004)

    Fulltext@MSK | Save
  • A phase II trial of busulfan, melphalan, and fludarabine followed by allogeneic T-cell depleted hematopoietic stem cell transplants from HLA-identical, or HLA-non identical related or unrelated donors for the treatment of advanced hematopoietic malignancies
    Meeting Abstract

    Boulad, F.; Jakubowski, A.; Castro-Malaspina, H.; Hsu, K. C.; Kernan, N. A.; Papadopoulos, E. B.; Perales, M. A.; Prockop, S. E.; Small, T. N.; van den Brink, M. R. M.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • Current results of donor leukocyte infusions (DLI) for treatment of Epstein-Barr virus associated lymphoproliferative disorders (EBVLPD) following related and unrelated T cell depleted bone marrow transplant (TCDBMT)
    Meeting Abstract

    Papadopoulos, E. B.; Small, T.; Ladanyi, M.; Boulad, F.; Castro-Malaspina, H.; Childs, B.; Kernan, N.; Mackinnon, S.; Szabolcs, P.; Young, J.; more...
    Blood (1996)

    Fulltext@MSK | Save
  • Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation
    Journal Article

    Papadopoulos, E. B.; Ladanyi, M.; Emanuel, D.; Mackinnon, S.; Boulad, F.; Carabasi, M. H.; Castro-Malaspina, H.; Childs, B. H.; Gillio, A. P.; Small, T. N.; more...
    New England Journal of Medicine (1994)

    Fulltext@MSK | Save